Detalhe da pesquisa
1.
Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to three months of imatinib therapy: final 5-year results from DASCERN.
Haematologica
; 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38695123
2.
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis.
Am J Hematol
; 99(4): 774-779, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38343062
3.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1588-1597, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37470365
4.
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial.
Am J Hematol
; 97(12): 1510-1519, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36054786
5.
Low-dose ruxolitinib shows effective in treating myelofibrosis.
Ann Hematol
; 100(1): 135-141, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33083863
6.
Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study.
Acta Haematol
; 142(3): 162-170, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31091521
7.
Influence of genetic polymorphisms of IL23R, STAT3, IL12B, and STAT4 on the risk of aplastic anemia and the effect of immunosuppressive therapy.
Ann Hematol
; 97(4): 685-695, 2018 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-29330562
8.
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Am J Hematol
; 98(7): E183-E186, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37128776
9.
Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina.
Blood
; 125(18): 2771-8, 2015 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-25766724
10.
[Clinical Efficacy of Second-generation Tyrosine Kinase Inhibitor in Treating Chronic Myeloid Leukemia].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 47(2): 287-91, 2016 Mar.
Artigo
Chinês
| MEDLINE | ID: mdl-27263312
11.
[Efficacy of tyrosine kinase inhibitor in treatment of chronic myeloid leukemia patients].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 45(4): 647-51, 2014 Jul.
Artigo
Chinês
| MEDLINE | ID: mdl-25286693
12.
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
J Cancer Res Clin Oncol
; 150(4): 189, 2024 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38605258
13.
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study.
Clin Lymphoma Myeloma Leuk
; 24(6): e257-e266, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38461040
14.
Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Ann Hematol
; 92(1): 89-96, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22992980
15.
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia.
Cancer Med
; 12(16): 17239-17252, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37409506
16.
Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
Biol Blood Marrow Transplant
; 18(10): 1509-16, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22469884
17.
Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case report and literature review.
J Cancer Res Clin Oncol
; 148(10): 2911-2919, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35933443
18.
Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.
Ann Med
; 54(1): 2627-2636, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36148999
19.
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.
J Hematol Oncol
; 15(1): 113, 2022 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35982483
20.
Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.
Front Psychiatry
; 12: 679932, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34168583